Throughout the MHS, the proportion of outpatient visits due to Influenza-Like Illness (ILI) increased substantially for all regions in Week 52 (through 29 December 2012); such increase is higher than previous seasons for all regions except in PACOM, where the ILI proportion is similar to previous seasons.
Influenza activity is at moderate levels across the overseas DoD laboratory surveillance network, except in Europe where the activity remains low; sites reported variable co-circulation of influenza A/H1, A/H3, and B.
The influenza vaccination coverage for the DoD (Active Duty component only) is 93%.
Reportable medical event data will be available at a later date.
DOD Laboratories/Partners (Weeks 50-52; through 29 December 2012):
Europe: Low influenza activity with co-circulation of influenza A/H3 and B (USEUCOM).
Southeast Asia: Moderate influenza activity with co-circulation of influenza A/H1, A/H3, and B (AFRIMS).
North Africa: Moderate influenza activity with co-circulation of influenza A/H1, A/H3, and B (NAMRU-3).
East Africa: Moderate influenza activity with circulation of influenza A/H3 only (USAMRU-K).
Central Africa: Moderate influenza activity with co-circulation of influenza A/H3 and B (USAMRU-K).
South America: Moderate influenza activity with co-circulation of influenza A/H1, A/H3, and B (NAMRU-6).
Influenza activity is at moderate levels across the overseas DoD laboratory surveillance network, except in Europe where the activity remains low; sites reported variable co-circulation of influenza A/H1, A/H3, and B.
The influenza vaccination coverage for the DoD (Active Duty component only) is 93%.
Reportable medical event data will be available at a later date.
DOD Laboratories/Partners (Weeks 50-52; through 29 December 2012):
Europe: Low influenza activity with co-circulation of influenza A/H3 and B (USEUCOM).
Southeast Asia: Moderate influenza activity with co-circulation of influenza A/H1, A/H3, and B (AFRIMS).
North Africa: Moderate influenza activity with co-circulation of influenza A/H1, A/H3, and B (NAMRU-3).
East Africa: Moderate influenza activity with circulation of influenza A/H3 only (USAMRU-K).
Central Africa: Moderate influenza activity with co-circulation of influenza A/H3 and B (USAMRU-K).
South America: Moderate influenza activity with co-circulation of influenza A/H1, A/H3, and B (NAMRU-6).
Comment